When investigating the presence of autoantibodies, 6 out of 16 CGD samples (37%) were positive for ANCA, while 3 out of 16 samples (19%) were positive for ANA (Table S1 in Supplementary Material). The gene discussed is BTG3; the disease is chronic granulomatous disease.